In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
|Articles|September 2, 2022
Information on the ACIP Interchangeability Guidance for Hepatitis B Vaccines
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
2
CKM Syndrome Stage Linked to CKD Odds, But Primary Care Hurdles Remain
3
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
4
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
5